|
MRK's Income from Cont. Operations Growth by Quarter and Year
Merck And Co Inc 's Income from Cont. Operations results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
Income from Cont. Operations Growth Y/Y▼
|
Income from Cont. Operations Growth Y/Y▼
|
| MRK Income from Cont. Operations (in millions $) |
FY 2020 |
FY 2019 |
FY 2018 |
FY 2017 |
| IV Quarter |
December |
-2,092.00
|
2,364.00
|
1,778.00
|
-1,038.00
|
| III Quarter |
September |
2,945.00
|
1,907.00
|
1,958.00
|
-51.00
|
| II Quarter |
June |
3,010.00
|
2,644.00
|
1,716.00
|
1,951.00
|
| I Quarter |
March |
3,219.00
|
2,862.00
|
741.00
|
1,556.00
|
| FY |
|
7,082.00
|
9,777.00
|
6,193.00
|
2,418.00
|
| MRK Income from Cont. Operations forth quarter 2020 Y/Y Growth Comment |
Merck and Co Inc in the forth quarter recorded loss from continued operations of $ -2,092.00 millions.
Looking into forth quarter results within Major Pharmaceutical Preparations industry 17 other companies have achieved higher Income from Cont. Operations growth. While Merck And Co Inc ' s Income from Cont. Operations no change of % ranks overall at the positon no. 920 in the forth quarter.
|
| MRK Income from Cont. Operations ( Y/Y Growth %) |
2020
|
2019 |
2018 |
2017 |
| IV Quarter |
December |
- |
32.96 % |
- |
- |
| III Quarter |
September |
54.43 % |
-2.6 % |
- |
- |
| II Quarter |
June |
13.84 % |
54.08 % |
-12.05 % |
61.37 % |
| I Quarter |
March |
12.47 % |
286.23 % |
-52.38 % |
37.7 % |
| FY |
|
-27.56 % |
57.87 % |
156.12 % |
-38.65 % |
MRK Income from Cont. Operations (Quarter on Quarter Growth %) |
2020
|
2019 |
2018 |
2017 |
| IV Quarter |
December |
- |
23.96 % |
-9.19 % |
- |
| III Quarter |
September |
-2.16 % |
-27.87 % |
14.1 % |
- |
| II Quarter |
June |
-6.49 % |
-7.62 % |
131.58 % |
25.39 % |
| I Quarter |
March |
36.17 % |
60.97 % |
- |
- |
| FY (Year on Year) |
|
-27.56 % |
57.87 % |
156.12 % |
-38.65 % |
| Income from Cont. Operations Y/Y Growth Statistics |
| High |
Average |
Low |
| 575.58 % |
39.25 % |
-92.46 % |
| (Jun 30 2019) |
|
(Dec. 30, 2010) |
|
|
| Income from Cont. Operations Y/Y Growth Statistics |
| High |
Average |
Low |
| 575.58 % |
39.25 % |
-92.46 % |
| (Jun 30 2019) |
|
(Dec. 30, 2010) |
|
| Income from Cont. Operations by Quarter for the Fiscal Years 2017, 2018, 2019, 2020 |
Merck And Co Inc 's Q/Q Income from Cont. Operations Growth
| Income from Cont. Operations Q/Q Growth Statistics |
| High |
Average |
Low |
| 0 % |
0 % |
0 % |
|
|
|
| MRK's IV. Quarter Q/Q Income from Cont. Operations Comment |
IV. Quarter 2020 loss from continued operations of -2,092.00 millions by Merck and Co Inc appear even worse if you take a look at loss from continued operations 2,945.00 millions in the third quarter.
Within Major Pharmaceutical Preparations industry Merck and Co Inc achieved highest sequential Income from Cont. Operations growth. While Merck And Co Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is . |
|
|
|
| Income from Cont. Operations Q/Q Growth Statistics |
| High |
Average |
Low |
| 0 % |
0 % |
0 % |
|
|
|
| MRK's IV. Quarter Q/Q Income from Cont. Operations Comment |
Recent loss from continued operations of -2,092.00 millions by Merck and Co Inc come out even worse if you take a look at 2,945.00 millions in the previous quarter.
Within Major Pharmaceutical Preparations industry Merck and Co Inc achieved highest sequential Income from Cont. Operations growth. While Merck And Co Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is . |
|
Merck And Co Inc 's 12 Months Income from Cont. Operations Growth Year on Year
Income from Cont. Operations TTM Growth |
12 Months Ending
(Dec 31 2020) |
12 Months Ending
(Sep 30 2020) |
12 Months Ending
(Jun 30 2020) |
12 Months Ending
(Mar 31 2020) |
12 Months Ending
(Dec 31 2019) |
| Cumulative Income from Cont. Operations 12 Months Ending |
$ 7,082.00 |
$ 11,538.00 |
$ 10,500.00 |
$ 10,134.00 |
$ 9,777.00 |
| Y / Y Income from Cont. Operations Growth (TTM) |
-27.56 % |
25.54 % |
13.61 % |
21.89 % |
57.87 % |
| Year on Year Income from Cont. Operations Growth Overall
Ranking |
# 983 |
# 520 |
# 305 |
# 267 |
# 179 |
| Seqeuential Income from Cont. Operations Change (TTM) |
-38.62 % |
9.89 % |
3.61 % |
3.65 % |
6.38 % |
| Seq. Income from Cont. Operations Growth (TTM) Overall
Ranking |
# 1270 |
# 700 |
# 676 |
# 341 |
# 394 |
| Cumulative Income from Cont. Operations growth
Comment |
For the 12 months ended Dec 31 2020 Merck And Co Inc reported a drop in Income from Cont. Operations by -27.56% year on year, to $7,082 millions, compare to the 25.54% growth at Sep 30 2020.
In the Healthcare sector 81 other companies have achieved higher trailing twelve month Income from Cont. Operations growth. While Income from Cont. Operations growth total ranking has deteriorated compare to previous quarter from 520 to 983. |
| Income from Cont. Operations TTM Q/Q Growth Statistics |
| High |
Average |
Low |
146.86 % |
7.07 % |
-87.73 % |
|
|
|
|
|
| Income from Cont. Operations TTM Y/Y Growth Statistics |
| High |
Average |
Low |
575.58 % |
39.25 % |
-92.46 % |
|
|
|
| Income from Cont. Operations TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 27 |
| Sector |
# 112 |
| S&P 500 |
# 1270 |
|
| Cumulative Income from Cont. Operations growth
Comment |
For the 12 months ended Dec 31 2020 Merck And Co Inc reported a drop in Income from Cont. Operations by -27.56% year on year, to $7,082 millions, compare to the 25.54% growth at Sep 30 2020.
In the Healthcare sector 81 other companies have achieved higher trailing twelve month Income from Cont. Operations growth. While Income from Cont. Operations growth total ranking has deteriorated compare to previous quarter from 520 to 983. |
| Income from Cont. Operations TTM Q/Q Growth Statistics |
| High |
Average |
Low |
146.86 % |
7.07 % |
-87.73 % |
|
|
|
| Income from Cont. Operations TTM Y/Y Growth Statistics |
| High |
Average |
Low |
575.58 % |
39.25 % |
-92.46 % |
|
|
|
| Income from Cont. Operations TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 27 |
| Sector |
# 112 |
| S&P 500 |
# 1270 |
|
